As per regional guidelines, she was referred to the eosinophilia team in the tertiary centre for approval of the anti-IL-5 therapy. Interleukin-5 is a key mediator for eosinophils; it is responsible for stimulating proliferation, maturation and differentiation of eosinophils. The gene discussed is IL5; the disease is Increased total eosinophil count.